We work on a case-by-case basis on behalf of both physicians and patients. In some cases, a physician is aware of a treatment option but needs assistance accessing it. Other times the physician is unaware of all the options and requests help with both finding and accessing them. Should a patient approach us we provide them with a comprehensive and impartial overview of their pre-approval treatment options in our Treatment Search Report.
In all cases our medical team works in tandem with our proprietary technology and uses patient-specific information - such as genomic profile - to accurately and rapidly identify relevant treatment options. Where appropriate, information regarding off-label use and treatments that are approved abroad is also provided. This process and the Treatment Search Report are free-of-charge and they help to reduce administrative burden, streamline physician-patient interaction and facilitate a more considered route to treatment.
If there is a suitable Clinical Trial to which your patient is eligible, then the first option is referral and enrolment in that trial. In many instances, however, patients who are eligible for these trials face other barriers to access such as geographical location or timing. Another subset may be at the right place at the right time and meet critical trial parameters but are excluded on the basis of factors such as comorbidities. For these types of patients, Expanded Access Programs (EAPs) may be an option. We work on behalf of you and your patient to navigate the complex and specialized world of pre-approval access and pursue all EAP treatment options. In addition, we have significant experience and expertise in this field, and with our biopharma partners we have established and run several EAPs across a number of disease areas.
Obtaining access to an investigational drug via Expanded Access can be a complicated and time-consuming process. myTomorrows is available to assist with each and every step. From initially liaising with the drug manufacturer on your behalf to expertly guiding regulatory submissions required to allow drug provision. Once regulatory authorities have signed off, our logistics processes adhere to best practice and coordinate with your pharmacy to ensure timeous and compliant delivery of the investigational drug. With your patient on treatment, additional support with respect to safety monitoring and Real-World Data (RWD) is also available.
We provide easy-to-source, comprehensive and up-to-date information about drugs in development around the world and facilitate access to them.